1Stockey RA, O'Brien C, Pye A, et al. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD[J]. Chest,2000,117(6) : 1638 - 1645
6Anzueto A, Niederman MS, Pearle J, et al. Community-Acquired Pneumonia Recovery In the Elderly(CAPRIE) :Efficacy and safety of moxifloxacin versus that of levofloxacin therapy[J]. Clin Infect Dis,2006,42(1) :73 - 81
7Wilson R,Jones P, Schaberg T. Antibiotic treatmment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis[J ]. Thorax, 2006,61 : 337 - 342
8Miravitlles M, Zalacain R, Murio C, et al. Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials. Result of a two-year study[J]. Clin Drug Invest,2003,23:439 - 450
二级参考文献40
1Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
2Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
3Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
4Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
5Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
7Seemunsal TA, Donaldson GC f Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2000,161 : 1608-1613.
8Buhl R, Farmer SG. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.Proc Am Thorac Soc.2004.1:136-142.
9Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, 1987,106 : 196-204.
10Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest,2000,117(5 Suppl 2) :398SM01S.
3Prim Care Respir J.2010 Nov 17.2010-07-0086-R2.10.4104.2010.00066.
4Salpeter SR,Buckley NS,Salpet er EE.Met a analysis:anticholinergics,but not bet a agonists,reduce severe exacerbat ionsand respirat ory mortality in COPD[J].J G.Int ern Med,2006,21(10):1011-1019.
5Shelley R. Salpeter MD,Nicholas S. Buckley,Edwin E. Salpeter PhD.Meta-analysis: Anticholinergics, but not β-agonists, reduce severe exacerbations and respiratory mortality in COPD[J].Journal of General Internal Medicine.2006(10)
